Cargando…
An international multidisciplinary consensus statement on MAFLD and the risk of CVD
BACKGROUND: Fatty liver disease in the absence of excessive alcohol consumption is an increasingly common condition with a global prevalence of ~ 25–30% and is also associated with cardiovascular disease (CVD). Since systemic metabolic dysfunction underlies its pathogenesis, the term metabolic (dysf...
Ejemplares similares
-
Pharmacological Therapeutics: Current Trends for Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)
por: Prasoppokakorn, Thaninee, et al.
Publicado: (2021) -
An international Delphi consensus statement on metabolic dysfunction-associated fatty liver disease and risk of chronic kidney disease
por: Sun, Dan-Qin, et al.
Publicado: (2023) -
MAFLD: How is it different from NAFLD?
por: Gofton, Cameron, et al.
Publicado: (2023) -
From MAFLD to hepatocellular carcinoma and everything in between
por: Bae, Sarah Da Won, et al.
Publicado: (2022) -
MAFLD: what 2 years of the redefinition of fatty liver disease has
taught us
por: Grabherr, Felix, et al.
Publicado: (2022)